385 related articles for article (PubMed ID: 19947375)
1. [Combined treatment of metastatic hormone-resistant prostate cancer].
Kaprin AD; Gafanov RA; Al'bitskiĭ IA; Fastovets SV
Vopr Onkol; 2009; 55(4):477-9. PubMed ID: 19947375
[No Abstract] [Full Text] [Related]
2. External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
Koontz BF; Lee WR
Arch Esp Urol; 2011 Oct; 64(8):858-64. PubMed ID: 22052767
[TBL] [Abstract][Full Text] [Related]
3. [Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer].
Kaprin AD; Gafanov PA; Fastovets SV
Vopr Onkol; 2009; 55(4):474-6. PubMed ID: 19947374
[No Abstract] [Full Text] [Related]
4. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic prostate cancer: new insights and developments].
Lorch A
Dtsch Med Wochenschr; 2013 Apr; 138(14):703-6. PubMed ID: 23533034
[No Abstract] [Full Text] [Related]
6. Hormone-refractory prostate cancer: what have we learned?
Wirth MP
BJU Int; 2007 Jul; 100 Suppl 2():56-9. PubMed ID: 17594362
[No Abstract] [Full Text] [Related]
7. The benefits of early androgen blockade.
Maroni PD; Crawford ED
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
[TBL] [Abstract][Full Text] [Related]
8. Present status and perspectives in the treatment of hormone-refractory prostate cancer.
Silvestris N; Leone B; Numico G; Lorusso V; De Lena M
Oncology; 2005; 69(4):273-82. PubMed ID: 16282706
[TBL] [Abstract][Full Text] [Related]
9. [Therapy for hormone-refractory prostate cancer].
Nishimura K; Takahara S; Nonomura N; Okuyama A
Nihon Rinsho; 2002 Dec; 60 Suppl 11():266-71. PubMed ID: 12599583
[No Abstract] [Full Text] [Related]
10. Radiation Therapy Oncology Group P-0014: a phase 3 randomized study of patients with high-risk hormone-naive prostate cancer: androgen blockade with 4 cycles of immediate chemotherapy versus androgen blockade with delayed chemotherapy.
Pienta KJ;
Urology; 2003 Dec; 62 Suppl 1():95-101. PubMed ID: 14747047
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy in advanced prostate cancer.
Forster TH; Stoffel F; Gasser TC
Front Radiat Ther Oncol; 2002; 36():49-65. PubMed ID: 11842755
[No Abstract] [Full Text] [Related]
12. Management of metastatic prostate cancer: the crucial role of geriatric assessment.
Droz JP; Chaladaj A
BJU Int; 2008 Mar; 101 Suppl 2():23-9. PubMed ID: 18307689
[TBL] [Abstract][Full Text] [Related]
13. Choice of first-line treatment for metastatic prostate cancer.
Prescrire Int; 2013 Feb; 22(135):51. PubMed ID: 23444511
[No Abstract] [Full Text] [Related]
14. Hormone resistance in prostate cancer.
Pilat MJ; Kamradt JM; Pienta KJ
Cancer Metastasis Rev; 1998-1999; 17(4):373-81. PubMed ID: 10453281
[No Abstract] [Full Text] [Related]
15. Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.
MacVicar GR; Hussain MH
Curr Opin Oncol; 2013 May; 25(3):252-60. PubMed ID: 23511665
[TBL] [Abstract][Full Text] [Related]
16. Overview of hormonal therapy for prostate cancer.
Carter HB; Isaacs JT
Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039
[No Abstract] [Full Text] [Related]
17. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Efstathiou E; Bozas G; Kostakopoulos A; Kastritis E; Deliveliotis C; Antoniou N; Skarlos D; Papadimitriou C; Dimopoulos MA; Bamias A
Urology; 2005 Jan; 65(1):126-30. PubMed ID: 15667877
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
19. [Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate].
Lopez S; Simon JM; Mazeron JJ
Bull Cancer; 2009 Mar; 96(3):261-70. PubMed ID: 19318304
[TBL] [Abstract][Full Text] [Related]
20. Secondary hormonal therapy.
Smith DC
Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]